2. Academic Validation
  3. Design, synthesis and biological evaluation of seco-A-pentacyclic triterpenoids-3,4-lactone as potent non-nucleoside HBV inhibitors

Design, synthesis and biological evaluation of seco-A-pentacyclic triterpenoids-3,4-lactone as potent non-nucleoside HBV inhibitors

  • Bioorg Med Chem Lett. 2018 May 15;28(9):1501-1506. doi: 10.1016/j.bmcl.2018.03.076.
Zhijian Li 1,  Qingxi Min 2,  Haoji Huang 1,  Ruixuan Liu 1,  Yongyan Zhu 1,  Quanhong Zhu 3
Affiliations

Affiliations

  • 1 School of Traditional Chinese Medicine, Southern Medical University, Guangzhou 510515, PR China.
  • 2 Integrated Hospital of Traditional Chinese Medicine, Southern Medical University, Guangzhou 510315, PR China.
  • 3 School of Traditional Chinese Medicine, Southern Medical University, Guangzhou 510515, PR China; Guangdong Provincial Key Laboratory of Chinese Medicine Pharmaceutics, Guangzhou 510515, PR China. Electronic address: zqh@smu.edu.cn.
PMID: 29627260 DOI: 10.1016/j.bmcl.2018.03.076
Abstract

A series of seco-A-pentacyclic triterpenoids-3,4-lactone were synthesized and the anti-HBV activities were evaluated in vitro. Several compounds inhibited the secretion of HBV antigen and the replication of HBV DNA in micromolar level. Compounds D7 and D10, seco-A-oleanane-3,4-lactone, suppressed the HBeAg secretion with IC50 values of 0.14 μM and 0.86 μM respectively, and the inhibitory activities were also confirmed by detecting the fluorescence intensity of FITC-labeled monoclonal mouse HBeAg antibody via flow cytometry. Compounds D7 and D10 as well as B4, ring-A cleaved 3,30-dioic acid, also displayed remarkable inhibition on both HBV DNA replication at the concentration of 25 μM and HBV cccDNA (covalently closed circularDNA) replication with IC50 values of 33.5 μM, 32.7 μM and 12.3 μM respectively.

Keywords

HBV cccDNA replication; HBeAg secretion inhibition; seco-A-triterpenoid-3,4-lactone.

Figures